Dexmedetomidine for modified electroconvulsive therapy: a dose-optimized treatment study
Dexmedetomidine pretreatment at 0.4 μg/kg optimizes MECT anesthesia by balancing hemodynamic control, reduced propofol use, and rapid recovery, establishing it as the recommended dose.
Authors
- Jun Shen (ORCID: https://orcid.org/0000-0002-8759-6921)
- Yang Jiang (ORCID: https://orcid.org/0000-0002-9078-3453)
- Dongqi Li
- Lei Chen (ORCID: https://orcid.org/0000-0001-8658-9060)
- Guang Zhu (ORCID: https://orcid.org/0000-0003-2350-0369)
- Cong Dai (ORCID: https://orcid.org/0000-0002-9565-6234)
- Anjiang Wang (ORCID: https://orcid.org/0000-0001-6670-6645)
- Xiaomin Li (ORCID: https://orcid.org/0000-0001-6056-6928)
- Yu Zhang (ORCID: https://orcid.org/0000-0003-0978-2363)
- Ke Qi (ORCID: https://orcid.org/0000-0002-3089-2041)
- Min Zhou (ORCID: https://orcid.org/0000-0002-1361-500X)
- Jian Ma
Institutions
- Anhui Business College (CN)
- Xian Yang Central Hospital (CN)
- West Anhui University (CN)
- Lu'an First People's Hospital (CN)
Publication Details
- Journal
- European journal of medical research
- Published
- 2025-04-04
- DOI
- https://doi.org/10.1186/s40001-025-02509-3
- Citations
- 2
- Primary Topic
- Electroconvulsive Therapy Studies
- Type
- article
- Field-Weighted Citation Impact
- 2.94
Funders
- Key Research and Development Projects of Shaanxi Province